• The Korean Journal of Physiology and Pharmacology
• /
• 제2권3호
• /
• pp.287-295
• /
• 1998

Diazepam is known to have cardiovascular depressive effects through a combined action on benzodiazepinergic receptor and the GABA receptor-chloride ion channel complex. Moreover, it is known that barbiturates also have some cardiovascular regulatory effects mediated by the central GABAergic system. Therefore, this study was undertaken to delineate the regulatory actions and interactions of these systems by measuring the responses of the cardiovascular system and renal nerve activity to muscimol, diazepam and pentobarbital, administered intracerebroventricularly in rabbits. When muscimol $(0.03{\sim}0.3\;{\mu}\;g/kg)$, diazepam $(10{\sim}100\;{\mu}\;g/kg)$ and pentobarbital $(1{\sim}10\;{\mu}\;g/kg)$ were injected into the lateral ventricle of the rabbit brain, there were similar dose-dependent decreases in blood pressure (BP) and renal nerve activity (RNA). The relative potency of the three drugs in decreasing BP and RNA was muscimol ＞ pentobarbital ＞ diazepam. Muscimol and pentobarbital also decreased the heart rate in a dose-dependent manner; however, diazepam produced a trivial, dose-independent decrease in heart rate. Diazepam $(30\;{\mu}g/kg)$ augmented the effect of muscimol $(0.1\;{\mu}g/kg)$ in decreasing blood pressure and renal nerve activity, but pentobarbital $(3\;{\mu}g/kg)$ did not. Bicuculline $(0.5\;{\mu}g/kg)$, a GABAergic receptor blocker, significantly attenuated the effect of muscimol in decreasing BP and RNA, either alone or with diazepam, and that of pentobarbital in decreasing BP and RNA, either alone or with muscimol. We inferred that the central benzodiazepinergic and barbiturate systems help regulate peripheral cardiovascular function by modulating the GABAergic system, which adjusts the output of the vasomotor center and hence controls peripheral sympathetic tone. Benzodiazepines more readily modulate the GABAergic system than barbiturates.

• Korean Journal of Acupuncture
• /
• 제29권1호
• /
• pp.23-36
• /
• 2012

Objectives : This study was conducted to investigate effective treatment point selection method using oppressive pain in acupoints as elementary attempt for standard methodology of clinical acupuncture studies. Methods : Twenty seven subjects with hypertension or within prehypertension category - systolic and diastolic blood pressure (BP) over 120/80mmHg - were divided into two groups, oppressive pain point treatment group and oppressive painless point treatment group. In oppressive pain point treatment group, single point acupuncture (SPA) was conducted for 16 sessions during 8 weeks on most oppressive painful point among 6 selected acupuncture points used in previous trials and clinic. As a SPA intervention, 15 minutes with deqi sensation- elevating manipulation was conducted on the treatment acupoint. Same process was conducted in oppressive painless point treatment group on most oppressive painless point with subject blinding. Results : Significant reduction was observed in both systolic and diastolic BP after short time intervention (15.5/8.8 mmHg, 10.7/7.1 mmHg, P<0.05, respectively at 1 week) and maintained for 8 weeks intervention period in all groups (12.8/8.0 mmHg, 19.4/12.6 mmHg, P<0.05, respectively). No significant difference of BP change between oppressive pain point treatment group (N=10) and oppressive painless point treatment group (N=9) was observed during 8 weeks study period. Conclusions : SPA treatment as used in this pilot study was effective for lowering BP in mild hypertensive population, but oppressive pain in acupoint had no effect on treatment. This present result suggests the possibility of SPA for hypertension treatment regardless of oppressive pain.

• 동아시아식생활학회지
• /
• 제17권4호
• /
• pp.554-562
• /
• 2007

본 연구는 식이 습관병 예방을 위한 건강식품을 개발하기 위한 기초 연구로써 계획되어 선행 연구와 문헌상의 기록을 바탕으로 한 천마의 여러 기능 중 혈류 개선 효과에 중점을 두고 그 기능을 과학적으로 확인하여 보고자 하였다 즉, 쌀뜨물을 주로하여 소화 흡수 및 면역력의 증강을 기대할 수 있고 독성 성분을 제거할 수 있으며, 더불어 활혈(活血) 및 청열량혈(靑熱凉血)기능을 가지는 천궁과 이수(利水) 및 안신(安神)작용을 하는 복령을 포제에 함께 이용하여 뇌혈류와심혈관 기능을 증진시키고자 하였다. 따라서 흰쥐를 대상으로 Laser-Doppler flowmeter system(LDF)을 이용하여 천마가 국소 뇌혈류량과 혈압에 미치는 효과를 관찰한 결과는 다음과 같다. 1. 천마를 0.1mg/kg, 1.0mg/kg 및 10.0 mg/kg 농도로 주사 시 농도 의존적으로 국소 뇌혈류량이 증가되었다. 2. 천마가 국소 뇌혈류량을 증가시키는 기전을 확인하기 위해 propranolol, atropine, methylene blue, indomethacin으로 전처리한 후 천마를 주사했을 때는 국소뇌혈류량에 유의한 변화를 관찰할 수 없었으나, anti-nitric oxide synthetase를 전처리한 후 천마를 주사했을 때는 국소 뇌혈류량이 유의적으로 증가함을 관찰할 수 있었다. 3. 천마를 0.1 mg/kg, 1.0 mg/kg 및 10.0 mg/kg 농도로 주사 시 농도 의존적으로 혈압이 저하되었다. 4. 천마가 어떤 기전으로 혈압의 변화를 초래하는지를 확인하기 위해 propranolol, atropine, methylene blue, indomethacin으로 전처리한 후 천마를 주사했을 때는 혈압에 유의한 변화를 관찰할 수 없었으나 anti-nitric oxide synthetase로 전처리한 후 천마를 주사했을 때에는 혈압이 유의적으로 저하되는 변화가 나타났다. 이상의 결과에서 포제 천마는 뇌혈류량을 증가시키고 혈압을 강하시키는 작용이 있음을 확인하였고, 그 기전은 nitric oxide 생성과 관련되어 나타나는 결과로 판단된다. 따라서 혈관 질환을 포함한 식이 습관병과 관계된 질환의 예방 및 치료의 보조 식이물로써 활용이 가능하다고 판단되며, 향후 포제 천마를 이용한 건강식품을 개발하고 완제품에 대한 유효성에 대한 연구를 수행할 때 기초 자료가 될 수 있을 것으로 사료된다.

• 한국식품영양과학회지
• /
• 제32권7호
• /
• pp.1095-1101
• /
• 2003

본 연구는 천마가 혈압에 미치는 영향을 평가하기 위하여 본태성고혈압쥐(SHR/NCrj)를 공시하여 고지방식이(lard, 10%)를 급여하면서 천마 분말과 50% 에탄올과 열수추출물이 수축기 혈압(systolic blood pressure)에 미치는 영향을 조사하였다. 고지방식이 4주와 고지방식 이와 천마식이 4주 등 총 8주간 시험 후 종료체중은 대조군(A)이 통계적으로 가장 높았고(p<0.05), 천마분말 1%군(C)이 가장 낮았다. 평균 성장률은 식이군간 차이가 없었고 대조군이 천마식이군에 비해 다소 높았다. 식이섭취량은 천마분말 10%군(D)과 열수추출물 2 brix군(G)이 가장 많았고 천마분말 5%군(C)과 열수추출물 10 brix군(H)이 유의하게 낮았다(P<0.05). 장기중 간장과 신장무게는 열수추출물군(H)이 유의하게 낮았고(p<0.05), 비장무게는 차이가 없었다. 정소무게는 천마분말군(C,D)이 유의하게 높았고, 열수추출물군(G, H)이 가장 낮았다(p<0.05). 혈청지질중 TC 함량은 대조군(A, B)이 가장 높았고, 천마식이군이 유의하게 낮았다(p<0.05). TG 함량은 식이군간 통계적인 차이가 없었다. HDL 함량은 대조군(A)과 천마분말 5%군(D)을 제외한 천마식이군이 유의하게 높은 반면(p<0.05), LDL 함량은 대조군(A, B)이 가장 높았고, 열수추출물군(E, G)이 유의하게 낮았다(p<0.05). 천마식이를 급여하기 전(생후 약 8주령)모든 SHR의 기준혈압은 176.7∼195.1 mmHg으로, 평균혈압은 185.7 $\pm$ 5.8 mmHg이었다. 천마식이를 급여한 후 14일이 경과시 50% 에탄올추출물군(F)과 열수추출물군(G, H)에서 혈압이 각각9.5, 19.0, 10.9 mmHg 감소하였고, 28일에는 특히 50% 에 탄올추출물군(E, F)에서 각각 13.1, 10.5 mmHg으로 유의하게 감소하였다. 천마식이 급여 전 기준혈압 대비 감소율은 50%에탄올(E, F)과 열수추출물군(G)에서 각각 16.8, 20.2, 11.7 mmHg으로써 유의한 혈압변화로 인정되었다. 이상의 결과에서 고지방식이를 급여한 SHR 실험쥐의 혈압강하에 천마의 50% 에탄올추출물(F)이 천마의 분말식이 및 열수추출물에 비해 수축기혈압을 유의하게 감소시킨 것으로 사료된다.

• 한국직업건강간호학회지
• /
• 제10권2호
• /
• pp.164-173
• /
• 2001

To find out the factors affecting to the cardiorespiratory fitness of some workers in Taejon area, cardiorespiratory fitness indices, blood pressure(BP), total cholesterol level(TC), body mass indices(BMI) and life style data were collected from 169 blue collar workers and 106 white collar workers, from September to October 2000. 1. Cardiorespiratory fitness indices were increased statistically significantly by aging(p <0.05), but these was no statistically significantly difference between blue collar workers and white collar workers. 2. These were no significantly difference between types of workers by BMI, BP, blood total cholesterol level, regular exercise, alcohol drinking, smoking and psychosocial stress. 3. Age and BMI were selected affecting factors to the cardiorespiratory fitness indices in blue collar workers by multiple regression analysis, but no affecting factors selected the white collar workers.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.421.3-422
• /
• 2002

Carvedilol is a nonselective $\beta$-adrenoblocking agent with vasodilating activities. The pharmacokinetics and pharmacodynamics of carvedilol were studied in healthy volunteers following single oral administration. After oral administration of carvedilol 25mg. blood samples were collected for a period of 30 hours. Plasma concentrations of carvedilol were determined by HPLC with spectrofluorometric detection. The effects of carvedilol on systolic and diastolic blood pressure (BP) and heart rate (HR) were measured during the same period. (omitted)

• 대한한의학회지
• /
• 제27권4호
• /
• pp.198-208
• /
• 2006

Background : Ginseng has traditionally been used in oriental countries to recover vital energy from Qi deficiency, and has shown various biomedical effects in the scientific literature. Recent reports suggest that ginseng could regulate blood pressure (BP), but much controversy still remains. Therefore, we intended to assess the anti-hypertensive effect of several ginseng types frequently used in clinics. We also investigated the anti-hypertensive effect on Koreans and Chinese, and by the body type according to Sasang Constitution Medicine (SCM). Methods : The study subjects were recruited from mildly hypertensive patients who exhibited pre-hypertension(120/80 to 139/89 mmHg) and stage I hypertension (140/90 to 159/99 mmHg) in Korea and China. After assigning the subjects into a Korean, a Chinese, a red, and an American ginseng group by randomization, we prescribed ginseng at a dose of 4.5 g per day for 4 weeks. To assess the anti-hypertensive effect, we compared the mean of systolic and diastolic BP between before and after ginseng medication using a 24-hour ambulatory blood pressure monitor (24 hr ABPM. We also monitored adverse effect and laboratory findings to secure the subjects' safety. In addition, all of the subjects in Korea consulted a specialist of Sasang Constitution Medicine to identify their constitutional type. Results : There were 64 subjects treated with Korean ginseng, 58 treated with Chinese ginseng, 33 treated with red ginseng, and 64 treated with American ginseng. Korean, Chinese, and American ginseng all reduced subjects' BP; Korean and Chinese ginseng showed more effect. The secondary analysis on the subjects' nationality revealed that all of the ginseng types showed more significant anti-hypertensive effect in Chinese patients than in Koreans. The third analysis on the constitutional type of SCM showed there was no significant difference in the effectiveness and the safety of ginseng among the constitutional types. Conclusions : We suggest ginseng, especially Panax ginseng without any steaming-drying process, could be useful for mild hypertension. Further, ginseng is safe regardless of subjects' constitutional type or type of ginseng within a dosage of 4.5g per day.

• Journal of Preventive Medicine and Public Health
• /
• 제41권4호
• /
• pp.255-264
• /
• 2008

Objectives: This study adopted a qualitative method to explore the layman's beliefs and experience concerning high blood pressure and its management in order to develop a strategy to increase adherence to proper medical treatment. Methods: Semi-structured interviews that focused on personal experiences with hypertension and its management were conducted with 26 hypertensive patients. The participants were selected according to a BP above 140/90 mmHg (hypertension stage 1), based on the seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (JNC-VII). The interviews lasted for approximately 30 minutes (range: 20-60 minutes). The resulting questions were formulated into open-ended questions. The interview questionnaire was composed 17 items to examine non-adherence to treatment and 19 items to examine adherence to treatment. Results: Most participants recognized that the direct cause of high blood pressure was unhealthy behavior rather than inheritance. Thus, the hypertensive patient believed they could recover their blood pressure to a normal level through removing the direct cause of hypertension (weight reduction, diet, exercise) instead of taking drugs. The reasons for these statements were that the drugs for controlling hypertension are not natural or they are artificial, and they may have side effects, and drugs are not treatment for the root cause of hypertension. Most of the hypertensive patients chose to manage their behaviors as soon as they knew their blood pressure was high. Therefore, we should not divide the subjects into two groups according to their taking drugs or not, but they should be divided into two groups according to their willingness or not to manage their condition. Conclusions: For developing a strategy for an individual approach to hypertension management, we need to develop a client-centered attitude and strategy. That is, we need to tailor our approach to individual cases to avoid generalizations and stereotyping when developing an adherence increasing strategy.

• 고려인삼학회:학술대회논문집
• /
• 고려인삼학회 1988년도 학술대회지
• /
• pp.87-91
• /
• 1988

고혈압 치료제를 투여한 19명의 고혈압환자에게 홍삼을 매일 3g씩 3개월간 투여하고 혈압과 생활상태를 조사하였다. 홍삼투여기간중에는 수축기 혈압이 현저히 감소하였으나, 이완기혈압과 심장박동에는 변화가 없었다. 환자 중 $89\%$가 생활상태가 현저히 개선되었는데 그중 불면, 갈증, 피로감, 기분, 성생활과 일반적인 상태등이 두드러졌다. 더욱이 이 기간 중에서 R-R 간격 변화계수가 개선되었다. 그러나 홍삼투여를 중단한 1개월 후에는 수축기 혈압과 생활상태를 나타내는 인자 등이 투여전의 상태로 다시 악화되었다. 이러한 결과로서 홍삼은 수축기 혈압을 저하시키며 고혈압 치료제를 투여한 환자에 있어서 생활상태를 개선시키는 것으로 사료된다.

• The Korean Journal of Physiology and Pharmacology
• /
• 제1권6호
• /
• pp.647-655
• /
• 1997

The purpose of present study is to investigate the influence of a spinal gamma-aminobutyric acid B($GABA_B$) receptor on a central regulation of blood pressure(BP) and heart rate(HR), and to define its mechanism in the spinal cord. In urethane-anesthetized, d-tubocurarine-paralyzed and artificially ventilated male Sprague-Dawley rats, intrathecal administration of drugs were carried out using injection cannula(33-gauge stainless steel) through the guide cannula(PE 10) which was inserted intrathecally at lower thoracic level through the puncture of a atlantooccipital membrane. Intrathecal injection of an $GABA_B$ receptor agonist, baclofen(30, 60, 100 nmol) decreased both BP and HR dose-dependently. Pretreatment with 8-bromo-cAMP(50 nmol), a cAMP analog, or glipizide(50 nmol), a ATP-sensitive $K^+$ channel blocker, attenuated the depressor and bradycardic effects of baclofen(100 nmol), but not with 8-bromo-cGMP(50 nmol), a cGMP analog. These results suggest that the $GABA_B$ receptor in the spinal cord plays an inhibitory role in central cardiovascular regulation and that this depressor and bradycardic actions are mediated by the decrease of cAMP via the inhibition of adenylate cyclase and the opening of $K^+$ channel.